August 2023
1. ANDRADE C
   How to Use Percentiles to Better Understand Standardized Mean Difference (SMD) as a Measure of Effect Size.
   J Clin Psychiatry. 2023;84:23f15028.
   

   >> Share

   
   July 2023
2. ANDRADE C
   Cholinesterase Inhibitors for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Questionably Significant Benefits.
   J Clin Psychiatry. 2023;84:23f15009.
   

   >> Share

   
   March 2023
3. BURKE AD, Goldfarb D
   Diagnosing and Treating Alzheimer Disease During the Early Stage.
   J Clin Psychiatry. 2023;84:LI21019AH3C.
   

   >> Share

   
   
4. LENZE EJ, Reiersen AM, Zorumski CF, Santosh PJ, et al
   Beyond "Psychotropic": Repurposing Psychiatric Drugs for COVID-19, Alzheimer's Disease, and Cancer.
   J Clin Psychiatry. 2023;84:22r14494.
   

   >> Share

   
   December 2022
5. ANDERSON A, Malone M
   The Differential Diagnosis and Treatment of Mild Cognitive Impairment and Alzheimer Disease.
   J Clin Psychiatry. 2022;84:BG21120COM4.
   

   >> Share

   
   
6. ANDERSON A, Malone M
   Recent Advances in Screening for Mild Cognitive Impairment and Alzheimer Disease.
   J Clin Psychiatry. 2022;84:BG21120COM3.
   

   >> Share

   
   November 2022
7. ICHO S, Korten N, Reus L, Belderok T, et al
   Relationship Between Sporadic Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders: A Study in Families.
   J Clin Psychiatry. 2022;83.
   

   >> Share

   
   October 2022
8. ARNAUD AM, Brister TS, Duckworth K, Foxworth P, et al
   Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review.
   J Clin Psychiatry. 2022;83.
   

   >> Share

   
   August 2022
9. BURKE AD, Goldfarb D
   Facilitating Treatment Initiation in Early-Stage Alzheimer Disease.
   J Clin Psychiatry. 2022;83.
   

   >> Share

   
   
10. BURKE AD, Goldfarb D
    Timely Diagnosis of Alzheimer Disease.
    J Clin Psychiatry. 2022;83.
    

    >> Share

    
    
11. ANDRADE C
    Psychotropic Drugs With Long Half-Lives: Implications for Drug Discontinuation, Occasional Missed Doses, Dosing Interval, and Pregnancy Planning.
    J Clin Psychiatry. 2022;83.
    

    >> Share

    
    February 2022
12. ANDRADE C
    Methylphenidate and Other Pharmacologic Treatments for Apathy in Alzheimer's Disease.
    J Clin Psychiatry. 2022;83.
    

    >> Share

    
    October 2021
13. LI CY, Tai YH, Dai YX, Chang YT, et al
    Association of Alopecia Areata and the Risk of Dementia: A Nationwide Cohort Study.
    J Clin Psychiatry. 2021;82.
    

    >> Share

    
    September 2021
14. ZANG F, Zhu Y, Liu X, Fan D, et al
    Polygenic Effects of the Lipid Metabolic Pathway Accelerated Pathological Changes and Disrupted Default Mode Network Trajectory Across the Alzheimer's Disease Spectrum.
    J Clin Psychiatry. 2021;82.
    

    >> Share

    
    June 2021
15. BURKE AD, Apostolova L
    Treatment Challenges and the Hope of Emerging Therapies in Early-Stage Alzheimer Disease.
    J Clin Psychiatry. 2021;82.
    

    >> Share

    
    May 2021
16. BURKE AD
    Can Emerging Therapies Resolve Unmet Needs With Current Treatment in Early-Stage Alzheimer Disease?
    J Clin Psychiatry. 2021;82.
    

    >> Share

    
    
17. GOLDFARB D
    Advances in Diagnosis of Alzheimer Disease and Emerging Treatment Targets.
    J Clin Psychiatry. 2021;82.
    

    >> Share

    
    
18. CHEN MH, Cheng CM, Tsai SJ, Tsai CF, et al
    Obsessive-Compulsive Disorder and Dementia Risk: A Nationwide Longitudinal Study.
    J Clin Psychiatry. 2021;82.
    

    >> Share

    
    
19. APOSTOLOVA L
    Early-Stage Alzheimer Primer: Pathophysiology, Diagnosis, and Assessment.
    J Clin Psychiatry. 2021;82.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share